Home
Sessions
Evolving Paradigms in High-Risk Breast Cancer: Optimization and Integration of Treatment Modalities Across the Disease Continuum
Simultaneous Integrated Boost in Hypofractionated Regional Lymph Node Irradiotherapy for cN3 Breast Cancer: Preliminary Report of a Prospective Phase 2 Single-Arm Trial

Sep 29

SS 40 - Evolving Paradigms in High-Risk Breast Cancer: Optimization and Integration of Treatment Modalities Across the Disease Continuum

320 - Simultaneous Integrated Boost in Hypofractionated Regional Lymph Node Irradiotherapy for cN3 Breast Cancer: Preliminary Report of a Prospective Phase 2 Single-Arm Trial

04:15pm - 04:25pm ET

Presenter(s)

Yutong Tan, MD - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical , Shenzhen,